RLMD - Relmada Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Relmada Therapeutics, Inc.
IPO Date: June 16, 2014
Sector: Healthcare
Industry: Biotech
Market Cap: $346.68M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.53 | 4.26%
Avg Daily Range (30 D): $0.15 | 3.52%
Avg Daily Range (90 D): $0.19 | 3.60%
Institutional Daily Volume
Avg Daily Volume: .49M
Avg Daily Volume (30 D): 1.04M
Avg Daily Volume (90 D): 1.27M
Trade Size
Avg Trade Size (Sh.): 128
Avg Trade Size (Sh.) (30 D): 111
Avg Trade Size (Sh.) (90 D): 91
Institutional Trades
Total Institutional Trades: 502
Avg Institutional Trade: $2.08M
Avg Institutional Trade (30 D): $1.16M
Avg Institutional Trade (90 D): $1.99M
Avg Institutional Trade Volume: .15M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.25M
Avg Closing Trade (30 D): $1.04M
Avg Closing Trade (90 D): $2.27M
Avg Closing Volume: 210.77K
 
News
Sep 1, 2026 @ 12:00 PM
Relmada Therapeutics to Participate at the Wells F...
Source: Na
Jun 29, 2026 @ 11:00 AM
Relmada Therapeutics Joins Russell 2000Ãโ€šÂ® and Ru...
Source: Na
May 5, 2026 @ 11:00 AM
Relmada Therapeutics to Present NDV-01 Abstracts a...
Source: Na
Mar 12, 2026 @ 11:00 AM
Relmada Therapeutics to Report Fourth Quarter 2025...
Source: Na
Feb 26, 2026 @ 5:07 PM
Psychedelic Medicine Advances: Here Are Five Compa...
Source: Prnewswire
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-.11 $-.22 $-.29
Diluted EPS $-.11 $-.22 $-.29
Revenue $M $M $M
Gross Profit
Net Income / Loss $-12.91M $-19.05M $-19.87M
Operating Income / Loss $-15.01M $-19.46M $-20.33M
Cost of Revenue
Net Cash Flow $1.56M $6.28M $2.11M
PE Ratio    
Splits
Sep 30, 2019 1:4
Aug 12, 2015 1:5